Objective: To describe temporal bone findings on computed tomography (CT) imaging in GJB2-related hearing loss (HL). We asked whether evaluation of the temporal bone is required in individuals with biallelic GJB2 mutations. Study Design: Randomized, blinded, controlled, prospective measurement. Methods: Blood from 264 pediatric cochlear implant users was analyzed for mutations in the GJB2 gene. Thirtysix aspects of the temporal bone on CT imaging were evaluated in 53 individuals (106 ears) with biallelic disease causing GJB2 mutations. A subset of patients was age matched and compared with normally hearing individuals. Subjects with biallelic GJB2 mutations were tested for mutations in the SLC26A4 gene to rule out Pendred syndrome as a confounding cause of large vestibular aqueduct syndrome. Results: Approximately 53% of ears of subjects (72% of subjects) with biallelic GJB2 mutations had at least one temporal bone anomaly. The most common findings were 1) dilated endolymphatic fossa (28%); 2) hypoplastic modiolus (25%); 3) large vestibular aqueduct (8%); 4) hypoplastic horizontal semicircular canal (8%); 5) hypoplastic cochlea (4%). Compared with normally hearing individuals, the GJB2 group had hypoplasia of the cochlear nerve canal, lateral semicircular canal vestibule, internal auditory canal (t tests, P < .001), and were 11 times more likely to have a hypoplastic modiolus. Dilated endolymphatic fossae were 1.4 times more common in the GJB2 group, and large vestibular aqueducts were 3 times more common in the GJB2 group, as compared with normally hearing controls. Conclusions: Temporal bone anomalies are common in GJB2-related HL, and imaging of the temporal bone should be included in routine evaluation of these individuals.
INTRODUCTION
Mutations in the GJB2 gene (connexin 26) are believed to be associated with bilateral sensorineural hearing loss (SNHL) without temporal bone computed tomography (CT) anomalies. [1] [2] [3] [4] Consequently, one paradigm for investigating childhood idiopathic SNHL recommends against imaging the temporal bone in children with biallelic GJB2 mutations. 5 The objective of this study was to see whether a battery of measures from CT imaging could identify temporal bone anomalies in individuals with GJB2-related HL. Identification of such anomalies would support the routine use of imaging in GJB2-related HL and would suggest that paradigms for investigating SNHL be revised to incorporate this investigation.
Autosomal recessive nonsyndromic HL is the most prevalent genetic cause of congenital HL, and 50% of profound cases are caused by mutations in the GJB2 gene. 4 The GJB2 gene encodes the connexin 26 (Cx26) protein, which is a component of gap junctions. Gap junctions in the cochlea allow potassium ions to be removed from endolymph to the stria vascularis to maintain endolymphatic homeostasis. 6 Mutations in Cx26 are presumed to result in altered potassium recirculation, leading to accumulation of potassium in the cochlear endolymph and causing hair cell dysfunction and deafness. 7 The phenotype profile of GJB2-related HL is heterogeneous and depends on the severity of the GJB2 mutation and its protein product. 4 More than 100 Cx26 mutations known to cause SNHL have been reported in 35 different countries. 8 The few small studies investigating temporal bone imaging in GJB2 deafness relied on visual inspection and did not find a reliable association between GJB2 mutations and temporal bone anomalies. Kenna et al. 9 investigated 18 children with biallelic GJB2 mutations and found one individual with asymmetry of the right modiolus. Preciado et al. 5 studied 21 children with biallelic GJB2 mutations and identified one borderline large vestibular aqueduct (LVA). Normal temporal bone CT imaging has been reported in separate groups of 19 and 23 individuals with biallelic GJB2 mutations. 2, 3 Green et al. 4 reported no cochlear abnormalities in any individuals referred for HL or cochlear implantation.
We recently demonstrated in children with syndromic HL that visual inspection combined with precise measurement of the temporal bone on CT imaging can detect many more anomalies than with visual inspection alone. 10 On the basis of this premise, the purpose of the present study was to describe temporal bone findings using visual inspection and direct measurement of CT imaging in individuals with GJB2-related HL. We asked whether evaluation of the temporal bone is required in individuals with biallelic GJB2 mutations.
MATERIALS AND METHODS

Subjects
Subjects were pediatric cochlear implant users with bilateral severe to profound SNHL. This project was approved by The Hospital for Sick Children Ethics Review Board. Blood was prospectively obtained from 264 nonsyndromic patients with nonprogressive SNHL after obtaining written consent from each child's parent/guardian. Patients with disease-causing biallelic GJB2 mutations were included. Normally hearing controls were sequential trauma patients with petrous CT studies identified by way of a radiology report text search program using keywords "petrous" and "trauma." A chart review yielded 32 individuals with CT imaging of the temporal bone who were nonsyndromic and who had a normal audiogram.
DNA Extraction and Mutation Analysis
DNA was extracted from whole blood using high salt (Gentra Systems, Inc, Minneapolis, MN) or spin column (Qiagen Inc., Valencia, CA) methods. Extracted DNA was stored in TE buffer (10 mmol/L Tris-HCl, 1 mmol/L EDTA pH 8.0). Mutation detection for the GJB2 gene was performed by direct sequencing of the coding region (exon 2) and the intron/exon boundaries. This process has been described in detail elsewhere. 11 Samples were sequenced in both directions.
Several patients with GJB2-related HL had a LVA, and therefore all patients with biallelic GJB2 mutations were tested for mutations in the SLC26A4 gene that is associated with Pendred syndrome and LVA. Mutation detection for the SLC26A4 gene was performed by direct bidirectional sequencing of the coding region and intron/exon boundaries of the gene (primers available on request). Polymerase chain reaction (PCR) reactions contained in a 50 uL volume 100 ng genomic DNA, 40 pmol each forward and reverse primer, 1.5 mmol buffer (1.5 mmol MgCl2, 500 mmol KCl, 100 mmol Tris-HCl, pH8.8), 200 mol each dNTP (Amersham Biosciences/GE Health Care, Piscataway, NJ), and 1.5 U Taq polymerase (Amplitaq Gold, Roche Molecular Systems, Pleasanton, CA). PCR conditions used were initial denaturation of 95°C 10 minutes; touchdown step cycle (15 cycles) 95°C for 30 seconds, 65.5°C to 58°C for 30 seconds decreasing 0.5°C per cycle, 72°C for 30 seconds; cycle (20 cycles) 95°C for 30 seconds, 58°C for 30 seconds, 72°C for 30 seconds; and final extension of 72°C for 2 minutes. Sequencing reactions were performed as described for GJB2 mutation detection.
Temporal Bone Evaluation
Temporal bone CT imaging previously obtained for clinical reasons was evaluated. Similar digitally stored CT imaging was available for GJB2 and control groups, which were randomized and displayed to a blinded neuroradiologist using the Centricity Picture Archiving Communication System (PACS) by General Electric. Items evaluated on each CT image appear in Table I . Precise measurements (recorded in millimeters and rounded to 2 decimal points) were made using electronic calipers provided by the PACS system. Immeasurable aspects of the temporal bone were categorized by visual inspection. Thirty-six aspects of each temporal bone were evaluated using CT imaging: 16 by direct measurement, 12 computed from direct measurement, and 8 by visual inspection. Thirty-three recordings from each ear were made on axial section, and three were made on coronal section.
Statistical Analysis
We report first temporal bone findings of all individuals with biallelic disease causing GJB2 mutations. Because certain temporal bone structures grow with age, we then compared a subset of the GJB2 group with age-matched controls. Measurements across groups were compared using t tests for continuous variables and Mann-Whitney tests for categorical data. Significance was defined as P Յ .001 after Bonferroni correction, which was used to raise the standard of proof when making multiple comparisons across temporal bones. Statistics reflect the number of ears evaluated. Because several criteria exist for diagnosing a large endolymphatic fossa (opening into aqueduct) and a dilated endolymphatic duct, we calculated positive and negative predictive values (PPV and NPV, respectively) to assess the probability that each of these criteria in isolation could predict the presence or absence of biallelic GJB2 mutations.
RESULTS
GJB2 Mutation Detection
Blood from 264 nonsyndromic pediatric cochlear implant users was analyzed for GJB2 mutations. Biallelic GJB2 mutations were identified in 56 (21%) patients. Eleven different disease causing GJB2 mutations were identified (Table II) . 8, 11, 12 The G109A(V37I) mutation has been described as a benign polymorphism and a disease causing mutation, and therefore, three subjects with this mutation were omitted from analysis. 11, 12 
SLC26A4 Mutation Detection
Blood from 53 subjects with biallelic GJB2 mutations was analyzed for mutations in the SLC26A4 gene (Pendred syndrome). None had homozygous SLC26A4 mutations. Four patients with biallelic GJB2 mutations were heterozygous for sequence changes in the SLC26A4 gene. One patient with the GJB2 genotype 35delG/35delG was heterozygous for a nonsense mutation T1790G (L597ϫ), which is likely disease causing. 13 Three additional patients were heterozygous for novel SLC26A4 sequence changes of unknown significance: one was heterozygous for C296T (T99M) (GJB2 genotype 35delG/167delT), another was heterozygous for an intronic change C1544 ϩ 9T (GJB2 genotype 35delG/ 35delG), and a third was heterozygous for C1488T (L496L) (GJB2 genotype 35delG/T107C). 13 
Temporal Bone Evaluation
Temporal bone CT imaging of 53 patients (106 ears) with biallelic disease-causing GJB2 mutations was reviewed. Subjects were 33 males, 20 females, with a mean age of 3.60 Ϯ 3.90 years. Approximately 53% (56/106) of ears had at least one temporal bone anomaly by judgment or measurement criteria. Approximately 72% (38/53) of subjects had at least one temporal bone anomaly, and 47% (18/38) of these subjects had bilateral anomalies. The most common findings were 1) dilated endolymphatic fossa (28.3% by judgment, 26.4% measuring greater than 2 mm, 29.2% by either judgment or measurement criteria) (Fig. 1) ; 2) modiolar deficiency (24.7% abnormal: 19% tall and narrow, 3.8% "c"-shaped, 1.9% absent) (Fig. 2) ; 3) LVA (14.2% by judgment, 7.5% measuring greater than the posterior semicircular canal, 1.9% measuring greater than 1.5 mm, 15.7% by either judgment or measurement criteria) (Fig. 3) ; 4) hypoplastic horizontal semicircular canal (7.5%) (Fig. 4) ; 5) hypoplastic cochlea (3.8%) (Fig. 2) ; 6) dilated ampulla (3.8%). Other abnormalities included four dehiscent posterior semicircular canals (Fig. 5) , two dehiscent superior semicircular canals, one pericochlear lucency, and one vestibular aqueduct extending into the ampulla. LVAs were more commonly large (93.3%) than extra large (6.7%) and more often had parallel (73.3%) rather than funnel shaped (26.7%) walls. 14 Within the GJB2 group, compound heterozygotes had 1.5 times more temporal bone anomalies than homozygotes (75% vs. 46%, respectively). Similarly, individuals with mutations other than homozygous 35delG had 1.4 times more temporal bone anomalies and were more likely to have an LVA by visual inspection, as compared with 35delG homozygotes (67% vs. 47%, respectively; MannWhitney, P Յ .001). Individuals with two truncating GJB2 mutations had a significantly shorter internal auditory canal length (t test, P Յ .001) and a 2% to 15% prevalence of LVA (depending on diagnostic criteria used, i.e., judgment, larger than 1.5 mm, larger than posterior semicircular canal) as compared with subjects possessing both truncating and nontruncating mutations (0% prevalence of LVA).
A subset of 21 patients (42 ears) from the GJB2 group were age matched and compared with 21 normally hearing controls (42 ears). Table III illustrates temporal bone measurements for both groups. Temporal bone anomalies were detected in 55% of the GJB2 group and 29% of controls. Subjects in the GJB2 group had a significantly smaller cochlear nerve canal width (Fig. 6 ) and were 11 times more likely to have an abnormally shaped modiolus (27% tall and narrow, 5% "c"-shaped, 5% absent) as compared with controls (3% "c"-shaped) (Mann-Whitney, P Յ .001) (Fig. 2 ). There was a trend for the GJB2 group to have smaller apical and basal turns of the cochlea (t test, P Ͼ .001) (Fig. 2) . The horizontal semicircular canal vestibule width-to-length ratio was significantly smaller in the GJB2 group, denoting that the vestibule is longer and narrower as compared with controls (Fig. 4) . There was a trend for the posterior semicircular canal to be smaller in the GJB2 group (t test, P Ͼ .001).
Approximately 33% of the GJB2 group and 25% of the control group had an enlarged endolymphatic fossa (Fig. 1) . Fossae in the GJB2 group were 1.4 times more likely to be evaluated as enlarged on the basis of visual inspection or measurement greater than 2.0 mm. The neuroradiologist's judgment based on visual inspection was as accurate as using measurement criteria. There was a trend for the width of the endolymphatic fossa to be larger in the GJB2 group as compared with controls (t test, P Ͼ .001). The probability that a person with an enlarged fossa (greater than 2 mm) had GJB2-related HL (PPV) was 64%, and the probability that a person with a fossa smaller than 2 mm had normal hearing (NPV) was 54%. An LVA was evident in 17% of the GJB2 group and 5% of controls by judgment criteria (Fig. 3) . The mean aqueduct diameter in the GJB2 group was 1.5 times larger than in controls. There was a trend toward a greater incidence of LVA in the GJB2 group using measurement criteria (Mann-Whitney, P Ͼ .001). When enlarged, aqueducts in the GJB2 group were more likely to have parallel walls rather than a funnel-shaped appearance. 14 When the LVA was defined as measuring greater than 1.5 mm, the sensitivity was 2%, specificity 100%, PPV 100%, and NPV 50%. When defined as measuring greater than the posterior semicircular canal, the sensitivity was 7%, specificity 100%, PPV 100%, and NPV 51%.
The internal auditory canal in the GJB2 group had a significantly smaller porous acousticus width (t test, P Յ .001) and a smaller mid-distance width (t test, P Ͼ .001) as compared with normally hearing controls (Fig. 7) . There was no difference in length of the internal auditory canal across groups.
DISCUSSION
GJB2 Mutation Detection.
Biallelic GJB2 mutations were identified in 56 of 264 (21%) cochlear implant users. The most commonly identified GJB2 mutation was 35delG, which is the most common GJB2 mutation worldwide. 8 We omitted subjects with the G109A(V37I) mutation because it has been reported as both a benign polymorphism and a disease-causing mutation, and its function may depend on the cultural background of the individual. 11, 12 SLC26A4 Mutation Detection. Four children were heterozygous (carriers) for novel SLC26A4 gene changes (1 nonsense mutation, 3 changes of unknown significance) and were considered to have GJB2-related HL (2 diseasecausing GJB2 mutations). Because all four SLC26A4 gene changes were heterozygous, they are not thought to be contributing to the phenotype seen in these patients. However, this finding reinforces the fact that individuals may inherit changes in several deafness related genes, complicating the analysis of a genetic etiology for their SNHL. 
Temporal Bone Evaluation
Greater than 50% of ears in the GJB2 group had temporal bone anomalies on CT imaging. The most common findings were dilated endolymphatic fossa, modiolar deficiency, and LVA (Figs. 1 to 3 ). This is not surprising given that Kenna et al. 9 described one child with a modiolar anomaly, and Preciado et al. 5 identified a child with a borderline LVA.
Within the GJB2 group, individuals with compound heterozygous mutations, mutations other than homozygous 35delG, and two truncating mutations, were more likely to have temporal bone anomalies as compared with homozygotes, biallelic 35delG mutations, and at least one nontruncating mutation, respectively. This suggests that mutation severity and the ability to produce a functional protein affects the degree of temporal bone irregularity.
A subset of children from the GJB2 group were age matched with normally hearing controls because certain aspects of the temporal bone grow with age. Temporal bone anomalies were detected almost twice as often in the GJB2 group as compared with controls (55% vs. 29%, respectively). This suggests that even though normally hearing individuals can have irregular temporal bones, irregularities are more common in GJB2 deafness.
In the inner ear, the GJB2 group had a smaller cochlear nerve canal, abnormally shaped modiolus, hypoplastic horizontal semicircular canal vestibule (Fig. 4) , and showed a trend toward a hypoplastic cochlea (Figs. 2  and 6 ). These results are consistent with previous findings of decreased evoked responses of the auditory nerve in GJB2 deafness, which likely resulted from a decreased number of spiral ganglion neurons. 11 Modiolar deficiency has been associated with endolymphatic gusher during stapes surgery or cochlear implantation. 15 Embryologically, labyrinthine development occurs between 3 and 8 weeks of gestation. 16 Vestibulocochlear hypoplasia in GJB2 deafness provides evidence for disruption of this process.
A dilated endolymphatic fossa was seen in one third of the GJB2 group and one quarter of controls, regardless of whether judgment or measurement criteria were used (Fig. 1) . A dilated fossa has been associated with vertigo, which may result from conduction of intracranial pressure changes into the vestibule through the aqueduct. 15 In this study, the probability that a person with a fossa larger than 2 mm had GJB2 deafness (PPV) was 64%, and the probability that a subject with a fossa smaller than 2 mm had normal hearing (NPV) was 54%. This suggests that using a cutoff of 2 mm should not be used in isolation to diagnose GJB2 related SNHL but may be helpful as an adjunctive measure. An LVA by visual inspection and measurement was three times more common in the GJB2 group as compared with controls (Fig. 3) . Interestingly, LVA was diagnosed by visual inspection only half as frequently as an enlarged fossa, and the number of LVAs decreased when measurement criteria were used (greater than 1.5 mm or greater than posterior semicircular canal). Defining the LVA as measuring greater than 1.5 mm attained a sensitivity of 2%, specificity 100%, PPV 100%, and NPV 50%, suggesting a high likelihood of association with GJB2 deafness, but suggests that using this criteria alone would miss the diagnosis in most people. Similarly, defining the LVA as measuring greater than the posterior semicircular canal attained sensitivity of 7%, specificity 100%, PPV 100%, and NPV 51%.
The internal auditory canal in the GJB2 group had a smaller porous width with a normal length, suggesting the canal is long and narrow compared with controls (Fig. 7) . During embryogenesis, the otic vesicle produces a growth factor that promotes survival of the vestibulocochlear nerve, which inhibits cartilage formation leading to formation of the internal auditory canal. 17 In GJB2-related HL, the hypoplastic labyrinth and modiolus may lead to underdevelopment of the vestibulocochlear nerve, which cannot maximally inhibit cartilage formation, resulting in a narrow internal auditory canal.
Implications
Results from this study have important implications on our understanding of the mechanism of GJB2 deafness. GJB2 deafness is presumed to result from irregular endolymphatic homeostasis. 6, 7 However, this study found a relation between GJB2 mutations and temporal bone anomalies. This suggests that either GJB2 mutations independently affect gap junction and bony labyrinthine development or that GJB2 mutations disrupt gap junctions and endolymphatic homeostasis, which then leads to irregular bony labyrinthine development.
Clinically, anomalous cochleovestibular anatomy has been associated with difficulty during and after cochlear implantation. In a large review at our institution of children with cochleovestibular anomalies, 17.5% had middle ear abnormalities, making it difficult to access the cochlea, 14% had a facial nerve with an aberrant course, precluding optimal cochleostomy placement, and 6.7% had perilymph leak at implantation. 14 Children with narrow cochlear nerve or internal auditory canals performed more poorly on tests of speech perception, and the author suggested they could be considered poorer candidates for implantation. 14 This is supported by our previous finding of decreased auditory nerve evoked responses in individuals with GJB2 deafness. 11 Results from the present study suggest that evaluation of the temporal bone in GJB2 related HL is necessary before implantation because of the information that may be gleaned from potentially identifying anomalous cochleovestibular anatomy.
CONCLUSION
Detailed evaluation of temporal bone imaging identified anomalies in over 50% of ears (72% of individuals) with GJB2-related HL. The most commonly identified abnormalities were 1) dilated endolymphatic fossa; 2) hypoplastic modiolus; 3) LVA; 4) hypoplastic semicircular canal; 5) hypoplastic cochlea. GJB2 deafness was also associated with a hypoplastic cochlear nerve canal and a narrow internal auditory canal. These anomalies may be associated with difficulties during and after cochlear implantation. Results suggest that imaging of the temporal bone should be performed in individuals with GJB2-related HL and that previously described diagnostic algorithms for investigating childhood SNHL should be revised to incorporate this important investigation.
